Shopping Cart

Vesting of Performance Rights and Appendix 2A

Vesting of Performance Rights and Appendix 2A

Imagion Biosystems has today advised that 2,500,000 performance rights have vested and were issued as ordinary shares to Executive Chairman and CEO, Bob Proulx today, Thursday 10 September, under the terms of Mr Proulx’s employment agreement.

The attached ASX announcements in relation to issue of shares to Mr Proulx as a result of vesting of performance rights were released to market.

Vesting of Performance Rights

Appendix 2A

Related Articles

2023 AGM Resolution Overview

Video Transcript: Robert Proulx, Imagion Biosystems’ President & CEO: [00:00:00] On April 24th, we sent out the notice of meeting for our annual general meeting

Read More

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.